about
Global profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells.Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases.Aldose reductase inhibition prevents colon cancer growth by restoring phosphatase and tensin homolog through modulation of miR-21 and FOXO3a.Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrestNovel aldose reductase inhibitors: a patent survey (2006--present).Development of aldose reductase inhibitors for the treatment of inflammatory disorders.AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program.Preventive cancer stem cell-based vaccination reduces liver metastasis development in a rat colon carcinoma syngeneic model.Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis.Babesia microti Aldo-keto Reductase-Like Protein Involved in Antioxidant and Anti-parasite Response.An improved approach for predicting drug-target interaction: proteochemometrics to molecular docking.Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO-1/AMPK pathway in colon cancer cells.Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.Systematic Understanding of the Mechanism of Salvianolic Acid A via Computational Target Fishing.Aldo-Keto Reductases Mediated Cytotoxicity of 2-Deoxyglucose: A Novel Anticancer Mechanism.Drug Repositioning for Effective Prostate Cancer Treatment.
P2860
Q35551436-84823935-1188-4D66-A9AA-A79A3664DA6CQ35825211-F47035C5-86D6-4755-BA27-E54428F089ADQ36645354-492F79F5-353C-4C98-8B68-2EA4EAB2D29CQ36905724-5479B4FD-4505-40BC-A339-C2F265B160BAQ38045440-F468ED7B-FC38-4E03-A4A5-3C6BD3E18BC2Q38148786-FE36AE94-B336-4833-8C47-BEA9DE5840F2Q38713230-486253E9-A191-4711-9583-4012A34AEFD2Q39236143-66163524-E666-4246-B3D4-F38D0FBBC029Q42366521-EE408CF0-F42C-41EC-BF78-4D74683FFC54Q42700266-2421EAD2-95EE-4A6F-8B05-58AAE1ADD91EQ46603422-A73E4689-81F8-42C5-B3C9-D4B84E5EC449Q47685602-957A049C-011A-43DE-8D2D-0EE4A6367573Q49848276-9985C115-DA15-47E0-B866-DFAF2210F059Q51050981-B595EDA9-74AC-4998-A1B3-24621ECDCEAEQ52607803-936F3680-F666-4F21-8B7F-18EA7E24CA85Q55254671-2288B3B1-6A79-42A8-8016-21E6E01CDBA2
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting aldose reductase for the treatment of cancer
@ast
Targeting aldose reductase for the treatment of cancer
@en
type
label
Targeting aldose reductase for the treatment of cancer
@ast
Targeting aldose reductase for the treatment of cancer
@en
prefLabel
Targeting aldose reductase for the treatment of cancer
@ast
Targeting aldose reductase for the treatment of cancer
@en
P2093
P2860
P1476
Targeting aldose reductase for the treatment of cancer
@en
P2093
Kota V Ramana
Ravinder Tammali
Satish K Srivastava
P2860
P304
P356
10.2174/156800911795655958
P577
2011-06-01T00:00:00Z